Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples